Merck & Co. Pivots To COVID-19 Treatments After Vaccines Disappoint

Program Halt Seen As 'Hit' To Vaccine-Making Reputation

 
• By Alaric DeArment
Coronavirus
Merck & Co. pivots as its coronavirus vaccines show disappointing efficacy.

More from R&D

More from Scrip